AlloVir Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
AlloVir is a biotechnology company focused on developing cell therapies to restore natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. Founded in 2013 (formerly ViraCyte), the company is based in Waltham, Massachusetts. Its approach relies on off-the-shelf, allogeneic, multi-virus-specific T cells designed to target a range of devastating viral pathogens in immunocompromised individuals, offering a scalable path to treatment or prevention and the potential to address up to six viruses with a single therapy. AlloVir operates in the biotechnology research sector and is advancing multiple mid- to late-stage clinical trials across its portfolio, focusing on immunocompromised patients vulnerable to viral infections. As a small-to-mid-sized enterprise, its activities are positioned within the U.S. biopharma landscape.
1-888-653-2347 
support@leadiq.com 
